Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetes intervention therapy

N K Maclaren1

  • 1Department of Pathology and Laboratory Medicine, University of Florida College of Medicine, Gainesville 32610.

Journal of Diabetes and Its Complications
|April 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Introduction.

Pediatric annals·2014
Same author

Diagnosis and treatment of diabetic ketoacidosis.

Pediatric annals·2014
Same author

Physiology of diabetes.

Pediatric annals·2014
Same author

Multiple autoantibodies as predictors of Type 1 diabetes in a general population.

Diabetologia·2003
Same author

Diabetes vaccines: a future to be realized.

Diabetes technology & therapeutics·2002
Same author

Medical care from childhood to adulthood in type 1 and type 2 diabetes.

Journal of endocrinological investigation·2001
Same journal

Diabetes and the risk of entrapment neuropathies of the upper and lower extremity - A propensity score-matched cohort study.

Journal of diabetes and its complications·2026
Same journal

Evaluation of the protective effects of liraglutide, dapagliflozin and their combination in rat kidneys of streptozotocin induced diabetes.

Journal of diabetes and its complications·2026
Same journal

From obesity guideline to diabetes practice: WHO GLP-1 recommendations between promise, uncertainty and global inequity.

Journal of diabetes and its complications·2026
Same journal

Impact of the AWGS2025 criteria on sarcopenia prevalence and microvascular complications in individuals with type 2 diabetes in Japan: a cross-sectional study.

Journal of diabetes and its complications·2026
Same journal

Clinical inertia in patients with type 2 diabetes: A retrospective cohort study using an electronic healthcare database in Japan.

Journal of diabetes and its complications·2026
Same journal

From static lipids to dynamic risk: The role of atherogenic index of plasma in prediabetes.

Journal of diabetes and its complications·2026
See all related articles

Intervention therapies targeting autoreactive T cells show promise for treating autoimmune diseases like type 1 diabetes. Strategies include T-cell vaccination and novel antibody therapies, alongside existing treatments.

Area of Science:

  • Immunology and Endocrinology
  • Autoimmune Disease Research

Background:

  • Autoreactive T cells play a critical role in the pathogenesis of autoimmune diseases, including insulin-dependent diabetes mellitus (type 1 diabetes).
  • Understanding the mechanisms of T-cell involvement opens avenues for targeted therapeutic interventions.

Purpose of the Study:

  • To explore potential intervention therapies for autoimmune diseases, focusing on insulin-dependent diabetes mellitus.
  • To review current and emerging strategies for modulating T-cell responses in the context of autoimmune diabetes.

Main Methods:

  • Review of preclinical studies in nonobese diabetic mouse models, including major histocompatibility complex modification and anti-I-A antibody administration.
  • Examination of T-cell vaccination as a preventative strategy in animal models.

Related Experiment Videos

  • Assessment of clinical strategies such as immunosuppressants (azathioprine, cyclosporine), antioxidant therapy (nicotinamide), and novel antibody development targeting T-cell receptors.

    • Main Results:

    • Preclinical models demonstrate successful inhibition of diabetes and insulitis through specific immune interventions.
    • T-cell vaccination has shown efficacy in preventing autoimmune disease in animal studies.
    • Various therapeutic strategies, from established drugs to novel approaches, are being evaluated for clinical application.

    Conclusions:

    • Modulating autoreactive T cells is a viable therapeutic strategy for autoimmune diabetes.
    • A range of interventions, including T-cell vaccination, antibody therapies, and established treatments, hold potential for managing type 1 diabetes.
    • Further research into specific oral tolerance, insulin prophylaxis, and other immunomodulatory approaches is warranted.